Bengaluru Genomics Center Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 9 Year, 9 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 145.61%
(FY 2022)
- Profit 234.30%
(FY 2022)
- Ebitda 228.16%
(FY 2022)
- Net Worth 346.98%
(FY 2022)
- Total Assets 25.82%
(FY 2022)
About Bengaluru Genomics Center
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajani Kantha, Pruthvi Thammaiah, Rahamathunnisa, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74900KA2015PTC084670
- Company No.
084670
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bengaluru Genomics Center?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajani Kantha  | Director | 24-Apr-2016 | Current |
| Pruthvi Thammaiah | Director | 15-Mar-2017 | Current |
| Rahamathunnisa | Director | 11-Dec-2015 | Current |
| Usha Shivanna | Director | 11-Dec-2015 | Current |
| Malali Gowda | Director | 13-May-2019 | Current |
Financial Performance and Corporate Structure Insights of Bengaluru Genomics Center.
Bengaluru Genomics Center Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 145.61% increase. The company also saw a substantial improvement in profitability, with a 234.3% increase in profit. The company's net worth Soared by an impressive increase of 346.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bengaluru Genomics Center?
In 2021, Bengaluru Genomics Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ripuhara Agro Private LimitedActive 9 years 5 months
Rajani Kantha and Pruthvi Thammaiah are mutual person
- Bioxverse Technologies Private LimitedActive 11 months 8 days
Rajani Kantha, Pruthvi Thammaiah and 2 more are mutual person
- Scientech Cropcare Private LimitedActive 14 years 2 months
Rajani Kantha and Pruthvi Thammaiah are mutual person
- Buddha Genomics Center Private LimitedActive 1 year
Rajani Kantha, Pruthvi Thammaiah and 1 more are mutual person
- Novish Farmer Foods Private LimitedInactive For E-Filing 8 months 16 days
Malali Gowda is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bengaluru Genomics Center?
Unlock and access historical data on people associated with Bengaluru Genomics Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bengaluru Genomics Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bengaluru Genomics Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
